Neuroblastoma classification: Difference between revisions

	Neuroblastoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neuroblastoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Neuroblastoma classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Neuroblastoma classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Neuroblastoma classification
CDC on Neuroblastoma classification
Neuroblastoma classification in the news
Blogs on Neuroblastoma classification
Directions to Hospitals Treating Neuroblastoma
Risk calculators and risk factors for Neuroblastoma classification

← Older edit

VisualWikitext

Latest revision as of 16:49, 1 March 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD [2]

Overview

International neuroblastoma pathology classification system is used for the classification of neuroblastic tumors. It is subdivided in 02 main categories based on the morphologic features of neuroblastic tumors into; schwannian stroma-poor and schwannian stroma-rich/dominant.

Classification

International neuroblastoma pathology classification, a system based on the framework of Shimada classification with minor modifications is proposed for international use in classification of neuroblastic tumors. ^[1]^[2]^[3]
It is a biologically relevant and pathologically significant classification system based on the morphologic features of neuroblastic tumors,i-e,neuroblastoma, ganglioneuroblastoma and ganglioneuroma.^[4]^[5]

Neuroblastic tumors

Schwannian stroma-poor group

Schwannian stroma-rich/dominant group

Undifferentiated neuroblastoma
Poorly differentiated neuroblastoma
Differentiating neuroblastoma

Nodular ganglioneuroblastoma
Intermixed ganglioneuroblastoma
Maturing ganglioneuroma
Mature ganglioneuroma

References

↑ Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015
↑ Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). "International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group". Cancer. 92 (9): 2451–61. PMID 11745303.
↑ Shimada, Hiroyuki; Ambros, Inge M.; Dehner, Louis P.; Hata, Jun-ichi; Joshi, Vijay V.; Roald, Borghild; Stram, Daniel O.; Gerbing, Robert B.; Lukens, John N.; Matthay, Katherine K.; Castleberry, Robert P. (1999). "The International Neuroblastoma Pathology Classification (the Shimada system)". Cancer. 86 (2): 364–372. doi:10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7. ISSN 0008-543X.
↑ H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi, B. Roald, D. O. Stram, R. B. Gerbing, J. N. Lukens, K. K. Matthay & R. P. Castleberry (1999). "The International Neuroblastoma Pathology Classification (the Shimada system)". Cancer. 86 (2): 364–372. PMID 10421273. Unknown parameter |month= ignored (help)
↑ H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi & B. Roald (1999). "Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee". Cancer. 86 (2): 349–363. PMID 10421272. Unknown parameter |month= ignored (help)

Template:WikiDoc Sources

[Stanford-1] Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015

[pmid11745303-2] Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). "International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group". Cancer. 92 (9): 2451–61. PMID 11745303.

[ShimadaAmbros1999-3] Shimada, Hiroyuki; Ambros, Inge M.; Dehner, Louis P.; Hata, Jun-ichi; Joshi, Vijay V.; Roald, Borghild; Stram, Daniel O.; Gerbing, Robert B.; Lukens, John N.; Matthay, Katherine K.; Castleberry, Robert P. (1999). "The International Neuroblastoma Pathology Classification (the Shimada system)". Cancer. 86 (2): 364–372. doi:10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7. ISSN 0008-543X.

[4] H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi, B. Roald, D. O. Stram, R. B. Gerbing, J. N. Lukens, K. K. Matthay & R. P. Castleberry (1999). "The International Neuroblastoma Pathology Classification (the Shimada system)". Cancer. 86 (2): 364–372. PMID 10421273. Unknown parameter |month= ignored (help)

[5] H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi & B. Roald (1999). "Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee". Cancer. 86 (2): 349–363. PMID 10421272. Unknown parameter |month= ignored (help)

[1]

[2]

[3]

[4]

[5]

@@ Line 1: / Line 1: @@
 {{Neuroblastoma}}
-{{CMG}}
+{{CMG}} {{AE}}{{ZAS}}
 ==Overview==
+International neuroblastoma pathology classification system is used for the classification of neuroblastic tumors. It is subdivided in 02 main categories based on the [[Morphology|morphologic features]] of neuroblastic tumors into; schwannian stroma-poor and schwannian stroma-rich/dominant.
+==Classification==
+* International neuroblastoma pathology classification, a system based on the framework of Shimada classification with minor modifications is proposed for international use in classification of neuroblastic tumors. <ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref><ref name="pmid11745303">{{cite journal| author=Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al.| title=International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. | journal=Cancer | year= 2001 | volume= 92 | issue= 9 | pages= 2451-61 | pmid=11745303 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11745303  }} </ref><ref name="ShimadaAmbros1999">{{cite journal|last1=Shimada|first1=Hiroyuki|last2=Ambros|first2=Inge M.|last3=Dehner|first3=Louis P.|last4=Hata|first4=Jun-ichi|last5=Joshi|first5=Vijay V.|last6=Roald|first6=Borghild|last7=Stram|first7=Daniel O.|last8=Gerbing|first8=Robert B.|last9=Lukens|first9=John N.|last10=Matthay|first10=Katherine K.|last11=Castleberry|first11=Robert P.|title=The International Neuroblastoma Pathology Classification (the Shimada system)|journal=Cancer|volume=86|issue=2|year=1999|pages=364–372|issn=0008-543X|doi=10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7}}</ref>
+* It is a biologically relevant and pathologically significant classification system based on the [[Morphology|morphologic features]] of neuroblastic tumors,i-e,neuroblastoma, ganglioneuroblastoma and [[ganglioneuroma]].<ref>{{Cite journal
+ | author = [[H. Shimada]], [[I. M. Ambros]], [[L. P. Dehner]], [[J. Hata]], [[V. V. Joshi]], [[B. Roald]], [[D. O. Stram]], [[R. B. Gerbing]], [[J. N. Lukens]], [[K. K. Matthay]] & [[R. P. Castleberry]]
+ | title = The International Neuroblastoma Pathology Classification (the Shimada system)
+ | journal = [[Cancer]]
+ | volume = 86
+ | issue = 2
+ | pages = 364–372
+ | year = 1999
+ | month = July
+ | pmid = 10421273
+}}</ref><ref>{{Cite journal
+ | author = [[H. Shimada]], [[I. M. Ambros]], [[L. P. Dehner]], [[J. Hata]], [[V. V. Joshi]] & [[B. Roald]]
+ | title = Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee
+ | journal = [[Cancer]]
+ | volume = 86
+ | issue = 2
+ | pages = 349–363
+ | year = 1999
+ | month = July
+ | pmid = 10421272
+}}</ref>
+<br>
+{{Family tree/start}}
+{{familytree  | | | | Y01 | | | | | | | | | | Y01=<div style="width: 20em; padding:0.5em;">''' Neuroblastic tumors'''</div>}}
+{{familytree  | | |,|-|^|-|.| | | | | | | | }}
+{{familytree  | | X01 | |  X02 | | | | | | |X01='''Schwannian stroma-poor group'''| X02='''Schwannian stroma-rich/dominant group'''}}
+{{familytree|boxstyle= border-top: 0px;| | A01 | |  A03 | | | | | | |A01=<div style="width: 20em; padding:1em;">
+'''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div>|A03=<div style="width: 20em; padding:1em;">
+'''Nodular ganglioneuroblastoma'''<br>'''Intermixed ganglioneuroblastoma'''<br>'''Maturing ganglioneuroma'''<br>'''Mature [[ganglioneuroma]]''' </div>}}
+{{Family tree/end}}
+<br>
 ==References==
 {{reflist|2}}
-[[de:Neuroblastom]]
-[[fr:Neuroblastome]]
-[[it:Neuroblastoma]]
-[[ja:神経芽細胞腫]]
-[[pl:Nerwiak płodowy]]
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}
@@ Line 18: / Line 49: @@
 [[Category:Disease]]
 [[Category:Pediatrics]]
+ [[Category:Up-To-Date]]
+[[Category:Oncology]]
+[[Category:Medicine]]
+[[Category:Neurology]]
+[[Category:Neurosurgery]]

Neuroblastoma classification: Difference between revisions

Latest revision as of 16:49, 1 March 2019

Overview

Classification

References

Navigation menu

Search